IMMUNOBIOME

Development of microbiome-mediated therapies targeting autoimmunity, transplant rejection, and neurological diseases... Microbiome-Targeted Therapeutics for Intractable Immune Diseases About Us Innovative and novel treatment therapies for hard-to-treat cancers, autoimmune diseases, allergies, organ transplant rejections, and neurological diseases Microbiome-derived drugs targeting the intestinal flora of patients Products and Services Personalized microbiome-derived medicine to redesign the disease-immune axis Microbiome-derived drugs that have fewer side effects and can enhance the therapeutic.

Also known as: ImmunoBiome Inc.

Primary location: Pohang South Korea